Ibrutinib – Pharmacology MCQ

Ibrutinib is used for the management of ?

A. Chronic Myelogenous Leukemia

B. Acute Lymphoblastic Leukemia

C. Mantle Cell Lymphoma

D. Lymphocyte rich Hodgkin’s Lymphoma

Correct answer : C. Mantle Cell Lymphoma

Ibrutinib is an orally administered selective inhibitor of Bruton’s tyrosine kinase (BTK)
It was approved by the US FDA on November 13, 2013 for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy
Dose: 560 mg once daily, taken orally

PG Blazer is aimed at helping undergraduate medical students in acquiring more knowledge and increasing their chance of getting admission to postgraduate courses by performing well in the post graduate medical entrance examinations. Students are requested verify the accuracy of information in standard text books. This site is not meant for any medical advice or treatment. Please contact your physician for medical advice and treatment.

Related Posts